These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 9215126)
21. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Adsay NV; Merati K; Andea A; Sarkar F; Hruban RH; Wilentz RE; Goggins M; Iocobuzio-Donahue C; Longnecker DS; Klimstra DS Mod Pathol; 2002 Oct; 15(10):1087-95. PubMed ID: 12379756 [TBL] [Abstract][Full Text] [Related]
22. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance. Zhang HK; Zhang QM; Zhao TH; Li YY; Yi YF World J Gastroenterol; 2004 Oct; 10(20):3044-7. PubMed ID: 15378790 [TBL] [Abstract][Full Text] [Related]
23. [Expression of mucin MUC1 and MUC2 in colorectal carcinoma and their clinical significance]. Huang WB; Shi LH; Zhu XQ; Xu GX; Qi Q Ai Zheng; 2002 Nov; 21(11):1231-4. PubMed ID: 12526222 [TBL] [Abstract][Full Text] [Related]
24. Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas. Feng H; Ghazizadeh M; Konishi H; Araki T Jpn J Clin Oncol; 2002 Dec; 32(12):525-9. PubMed ID: 12578901 [TBL] [Abstract][Full Text] [Related]
25. Coexpression of MUC1 with p53 or MUC2 correlates with lymph node metastasis in colorectal carcinomas. Jang KT; Chae SW; Sohn JH; Park HR; Shin HS J Korean Med Sci; 2002 Feb; 17(1):29-33. PubMed ID: 11850585 [TBL] [Abstract][Full Text] [Related]
26. Clinical significance of MUC1 and MUC2 mucin and p53 protein expression in colorectal carcinoma. Matsuda K; Masaki T; Watanabe T; Kitayama J; Nagawa H; Muto T; Ajioka Y Jpn J Clin Oncol; 2000 Feb; 30(2):89-94. PubMed ID: 10768872 [TBL] [Abstract][Full Text] [Related]
27. Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis. Tamada S; Goto M; Nomoto M; Nagata K; Shimizu T; Tanaka S; Sakoda K; Imai K; Yonezawa S Pathol Int; 2002 Nov; 52(11):713-23. PubMed ID: 12685548 [TBL] [Abstract][Full Text] [Related]
28. Phenotypic alterations of mucins and cytokeratins during gallbladder carcinogenesis. Chang HJ; Kim SW; Lee BL; Hong EK; Kim WH Pathol Int; 2004 Aug; 54(8):576-84. PubMed ID: 15260848 [TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical study of MUC1, MUC2 and MUC5AC in colorectal carcinoma and review of literature. Kesari MV; Gaopande VL; Joshi AR; Babanagare SV; Gogate BP; Khadilkar AV Indian J Gastroenterol; 2015 Jan; 34(1):63-7. PubMed ID: 25731647 [TBL] [Abstract][Full Text] [Related]
30. Mucin core protein expression by colorectal mucinous carcinomas with or without mucus hyperplasia. Ishizu H; Kumagai J; Eishi Y; Takizawa T; Koike M J Gastroenterol; 2004; 39(2):125-32. PubMed ID: 15069618 [TBL] [Abstract][Full Text] [Related]
31. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung. Awaya H; Takeshima Y; Yamasaki M; Inai K Am J Clin Pathol; 2004 May; 121(5):644-53. PubMed ID: 15151204 [TBL] [Abstract][Full Text] [Related]
32. Expression of mucin core proteins, trefoil factors, APC and p21 in subsets of colorectal polyps and cancers suggests a distinct pathway of pathogenesis of mucinous carcinoma of the colorectum. Kim DH; Kim JW; Cho JH; Baek SH; Kakar S; Kim GE; Sleisenger MH; Kim YS Int J Oncol; 2005 Oct; 27(4):957-64. PubMed ID: 16142311 [TBL] [Abstract][Full Text] [Related]
33. Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis. Akyürek N; Akyol G; Dursun A; Yamaç D; Günel N Pathol Res Pract; 2002; 198(10):665-74. PubMed ID: 12498221 [TBL] [Abstract][Full Text] [Related]
34. MUC1 and MUC2 expression in salivary gland tumors and in non-neoplastic salivary gland tissue. Mannweiler S; Beham A; Langner C APMIS; 2003 Oct; 111(10):978-84. PubMed ID: 14616551 [TBL] [Abstract][Full Text] [Related]
35. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. Yonezawa S; Nakamura A; Horinouchi M; Sato E J Hepatobiliary Pancreat Surg; 2002; 9(3):328-41. PubMed ID: 12353144 [TBL] [Abstract][Full Text] [Related]
36. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas. Manne U; Weiss HL; Grizzle WE Clin Cancer Res; 2000 Oct; 6(10):4017-25. PubMed ID: 11051251 [TBL] [Abstract][Full Text] [Related]
37. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723 [TBL] [Abstract][Full Text] [Related]
38. Fhit, Mlh1, P53 and phenotypic expression in the early stage of colorectal neoplasms. Yasugi A; Yashima K; Hara A; Koda M; Kawaguchi K; Harada K; Andachi H; Murawaki Y Oncol Rep; 2008 Jan; 19(1):41-7. PubMed ID: 18097574 [TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical evaluation of mucin expression in precancerous tissue of stomach. Vernygorodskyi S Exp Oncol; 2013 Jun; 35(2):114-7. PubMed ID: 23828387 [TBL] [Abstract][Full Text] [Related]
40. Correlative histochemical study providing evidence for the dual nature of human colorectal cancer mucin. Ajioka Y; Xing PX; Hinoda Y; Jass JR Histochem J; 1997 Feb; 29(2):143-52. PubMed ID: 9147071 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]